Evidence map›Paper›PMID 27798657›Full record

ArticlePloS one2016

The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury.

Ivana Gaziova, Daniel Jackson, Paul J Boor, Dwayne Carter, Zobeida Cruz-Monserrate, Cornelis J Elferink, Aditya D Joshi, Bhupendra Kaphalia, Craig D Logsdon, Karen Pereira de Castro and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ivana GaziovaDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States of America.
Daniel JacksonDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States of America.
Paul J BoorDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States of America.
Dwayne CarterDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States of America.
Zobeida Cruz-MonserrateDivision of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Cornelis J ElferinkDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States of America.
Aditya D JoshiDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States of America.
Bhupendra KaphaliaDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States of America.
Craig D LogsdonDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Karen Pereira de CastroDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States of America.
Lynn SoongDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States of America.
Xinrong TaoDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States of America.
Suimin QiuDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States of America.
Lisa A ElferinkDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, United States of America.
The University of Texas Medical Branch at Galveston · USThe Ohio State University Wexner Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Project 3: Toxicology of Petrogenic PAH in the Gulf Oil SpillU19ES020676 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 2011 to 2015
$7.9M
MOLECULAR MECHANISMS OF PANCREATITISR01DK052067 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGSDON, CRAIG D · 1998 to 2015
$4.4M
Novel Mechanism of aryl hydrocarbon receptor-mediated differential gene regulationR01DK122028 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Aditya D Joshi · 2019 to 2026
$2.3M
Aryl Hydrocarbon Receptor-Mediated Epigenetic ProcessesR01ES026874 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 2016 to 2020
$2.2M
A Novel Paradigm for Aryl Hydrocarbon Receptor SignalingR21ES024607 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 2015 to 2016
$426k
Pancreatic Regeneration from Alcohol-Associated InjuryR21AA024290 · NIAAA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ELFERINK, LISA A. · 2015 to 2016
$407k
Characterization of cinnabarinic acid mediated cytoprotection upon liver injuryK01DK102514 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI JOSHI, ADITYA D · 2015 to 2017
$279k
A Global Characterization of the Interaction Between the AhR and KLF-6F31ES023305 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI JACKSON, DANIEL · 2014 to 2015
$44k
NIAAA NIH HHS R21 AA024290NIDDK NIH HHS R01 DK052067NIDDK NIH HHS R01 DK122028NIEHS NIH HHS F31 ES023305NIEHS NIH HHS P30 ES006676NIEHS NIH HHS R01 ES026874NIEHS NIH HHS R21 ES024607NIEHS NIH HHS U19 ES020676
6 · The paper itself

Abstract

Acinar cells represent the primary target in necroinflammatory diseases of the pancreas, including pancreatitis. The signaling pathways guiding acinar cell repair and regeneration following injury remain poorly understood. The purpose of this study was to determine the importance of Hepatocyte Growth Factor Receptor/MET signaling as an intrinsic repair mechanism for acinar cells following acute damage and chronic alcohol-associated injury. Here, we generated mice with targeted deletion of MET in adult acinar cells (MET-/-). Acute and repetitive pancreatic injury was induced in MET-/- and control mice with cerulein, and chronic injury by feeding mice Lieber-DeCarli diets containing alcohol with or without enhancement of repetitive pancreatic injury. We examined the exocrine pancreas of these mice histologically for acinar death, edema, inflammation and collagen deposition and changes in the transcriptional program. We show that MET expression is relatively low in normal adult pancreas. However, MET levels were elevated in ductal and acinar cells in human pancreatitis specimens, consistent with a role for MET in an adaptive repair mechanism. We report that genetic deletion of MET in adult murine acinar cells was linked to increased acinar cell death, chronic inflammation and delayed recovery (regeneration) of pancreatic exocrine tissue. Notably, increased pancreatic collagen deposition was detected in MET knockout mice following repetitive injury as well alcohol-associated injury. Finally, we identified specific alterations of the pancreatic transcriptome associated with MET signaling during injury, involved in tissue repair, inflammation and endoplasmic reticulum stress. Together, these data demonstrate the importance of MET signaling for acinar repair and regeneration, a novel finding that could attenuate the symptomology of pancreatic injury.

Indexed as

Wound HealingAcinar CellsAcute DiseaseAlcohol DrinkingAnimalsCeruletideChronic DiseaseCollagenDisease Models, AnimalGene DeletionHumansInflammationMacrophagesMice, Inbred C57BLPancreasPancreatitis, ChronicCeruletideCollagenProto-Oncogene Proteins c-met

Identifiers

PMID27798657
PMCPMC5087859
OpenAlexW2544421112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.